Early Lesion of Post-Primary Tuberculosis: Subclinical Driver of Disease and Target for Vaccines and Host-Directed Therapies

The characteristic lesion of primary tuberculosis is the granuloma as is widely studied in human tissues and animal models. Post-primary tuberculosis is different. It develops only in human lungs and begins as a prolonged subclinical obstructive lobular pneumonia that slowly accumulates mycobacteria...

Full description

Bibliographic Details
Main Authors: Robert E. Brown, Robert L. Hunter
Format: Article
Language:English
Published: MDPI AG 2021-12-01
Series:Pathogens
Subjects:
Online Access:https://www.mdpi.com/2076-0817/10/12/1572
_version_ 1797501636115955712
author Robert E. Brown
Robert L. Hunter
author_facet Robert E. Brown
Robert L. Hunter
author_sort Robert E. Brown
collection DOAJ
description The characteristic lesion of primary tuberculosis is the granuloma as is widely studied in human tissues and animal models. Post-primary tuberculosis is different. It develops only in human lungs and begins as a prolonged subclinical obstructive lobular pneumonia that slowly accumulates mycobacterial antigens and host lipids in alveolar macrophages with nearby highly sensitized T cells. After several months, the lesions undergo necrosis to produce a mass of caseous pneumonia large enough to fragment and be coughed out to produce a cavity or be retained as the focus of a post-primary granuloma. Bacteria grow massively on the cavity wall where they can be coughed out to infect new people. Here we extend these findings with the demonstration of secreted mycobacterial antigens, but not acid fast bacilli (AFB) of <i>M. tuberculosis</i> in the cytoplasm of ciliated bronchiolar epithelium and alveolar pneumocytes in association with elements of the programmed death ligand 1 (PD-L1), cyclo-oxygenase (COX)-2, and fatty acid synthase (FAS) pathways in the early lesion. This suggests that M. tuberculosis uses its secreted antigens to coordinate prolonged subclinical development of the early lesions in preparation for a necrotizing reaction sufficient to produce a cavity, post-primary granulomas, and fibrocaseous disease.
first_indexed 2024-03-10T03:22:23Z
format Article
id doaj.art-5807119b50c54ed8894fac9a2663a30b
institution Directory Open Access Journal
issn 2076-0817
language English
last_indexed 2024-03-10T03:22:23Z
publishDate 2021-12-01
publisher MDPI AG
record_format Article
series Pathogens
spelling doaj.art-5807119b50c54ed8894fac9a2663a30b2023-11-23T10:00:51ZengMDPI AGPathogens2076-08172021-12-011012157210.3390/pathogens10121572Early Lesion of Post-Primary Tuberculosis: Subclinical Driver of Disease and Target for Vaccines and Host-Directed TherapiesRobert E. Brown0Robert L. Hunter1Department of Pathology and Laboratory Medicine, University of Texas Health Sciences Center at Houston, Houston, TX 77030, USADepartment of Pathology and Laboratory Medicine, University of Texas Health Sciences Center at Houston, Houston, TX 77030, USAThe characteristic lesion of primary tuberculosis is the granuloma as is widely studied in human tissues and animal models. Post-primary tuberculosis is different. It develops only in human lungs and begins as a prolonged subclinical obstructive lobular pneumonia that slowly accumulates mycobacterial antigens and host lipids in alveolar macrophages with nearby highly sensitized T cells. After several months, the lesions undergo necrosis to produce a mass of caseous pneumonia large enough to fragment and be coughed out to produce a cavity or be retained as the focus of a post-primary granuloma. Bacteria grow massively on the cavity wall where they can be coughed out to infect new people. Here we extend these findings with the demonstration of secreted mycobacterial antigens, but not acid fast bacilli (AFB) of <i>M. tuberculosis</i> in the cytoplasm of ciliated bronchiolar epithelium and alveolar pneumocytes in association with elements of the programmed death ligand 1 (PD-L1), cyclo-oxygenase (COX)-2, and fatty acid synthase (FAS) pathways in the early lesion. This suggests that M. tuberculosis uses its secreted antigens to coordinate prolonged subclinical development of the early lesions in preparation for a necrotizing reaction sufficient to produce a cavity, post-primary granulomas, and fibrocaseous disease.https://www.mdpi.com/2076-0817/10/12/1572tuberculosissecretory antigensbronchiolar epitheliumalveolar pneumocytesM2 polarizationCOX-2
spellingShingle Robert E. Brown
Robert L. Hunter
Early Lesion of Post-Primary Tuberculosis: Subclinical Driver of Disease and Target for Vaccines and Host-Directed Therapies
Pathogens
tuberculosis
secretory antigens
bronchiolar epithelium
alveolar pneumocytes
M2 polarization
COX-2
title Early Lesion of Post-Primary Tuberculosis: Subclinical Driver of Disease and Target for Vaccines and Host-Directed Therapies
title_full Early Lesion of Post-Primary Tuberculosis: Subclinical Driver of Disease and Target for Vaccines and Host-Directed Therapies
title_fullStr Early Lesion of Post-Primary Tuberculosis: Subclinical Driver of Disease and Target for Vaccines and Host-Directed Therapies
title_full_unstemmed Early Lesion of Post-Primary Tuberculosis: Subclinical Driver of Disease and Target for Vaccines and Host-Directed Therapies
title_short Early Lesion of Post-Primary Tuberculosis: Subclinical Driver of Disease and Target for Vaccines and Host-Directed Therapies
title_sort early lesion of post primary tuberculosis subclinical driver of disease and target for vaccines and host directed therapies
topic tuberculosis
secretory antigens
bronchiolar epithelium
alveolar pneumocytes
M2 polarization
COX-2
url https://www.mdpi.com/2076-0817/10/12/1572
work_keys_str_mv AT robertebrown earlylesionofpostprimarytuberculosissubclinicaldriverofdiseaseandtargetforvaccinesandhostdirectedtherapies
AT robertlhunter earlylesionofpostprimarytuberculosissubclinicaldriverofdiseaseandtargetforvaccinesandhostdirectedtherapies